Medical Device Network:
ChromaCode has formed a partnership with MedGenome to launch its high-definition polymerase chain reaction (HDPCR) multiplexing technology in India and the Middle East regions.
HDPCR technology is designed to enable deep multiplexing for the assessment of actionable biomarkers in a single assay for various sample types.
Its applications span several fields including oncology, minimal residual disease, transplant and noninvasive prenatal testing.
